Skip to main content

Table 4 Associations between incident TDD and various dichotomous clinical factors during a period of 2 years (n = 3104).

From: Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting

 

TDD rate exposed

TDD rate non-exposed

   

Clinical factor

N

Person yearsa

Rate (%)

N

Person years

Rate (%)

HR adjusted (95% CI)

HR unadjusted (95% CI)

Sensitivity analyses (HR adjusted) 95% CI)b

Sexual dysfunction

44

505

8.7

84

2637

3.2

2.68

(1.72, 4.16)*

2.72

(2.20, 3.37)*

2.61

(1.56, 4.39)*

Amenorrhea

11

126

8.7

107

2810

3.8

2.54

(2.10, 3.09)*

2.38

(1.74, 3.26)*

2.48

(1.83, 3.36)*

Extra-pyramidal symptoms

89

273

32.6

40

2875

1.4

13.94 (6.90, 28.19)*

17.20

(9.11, 32.47)*

17.79

(6.70, 47.26)*

FGA use vs no AP

31

287

10.8

9

768

1.2

2.64 (1.94, 3.60)*

2.64

(1.97, 3.53)*

2.32

(1.66, 3.24)*

SGA use vs no AP

69

1902

3.6

9

768

1.2

2.18 (1.20, 3.97)†

2.16

(1.02, 4.54)†

1.50

(0.79, 2.85)

  1. *P ≤ 0.001; †P ≤ 0.05 N = min. 1143 (as amenorrhea analysis was limited to women), max. 2025 for the adjusted analyses; n = min. 1606, max. 2953 for the unadjusted analyses. aPerson years in follow-up. For instance, for sexual dysfunction, the patients included in the analyses contributed (505 + 2637=) 3142 years of follow-up time. 44 patients that developed TDD presented with comorbid sexual dysfunction (rate of 8.7%). 84 patients that developed TDD did not present with comorbid sexual dysfunction (rate of 3.2%). bSensitivity analyses were conducted with a stricter criterion for incidence TDD; a stricter risk set was defined as the sample of patients free from dystonia or TD at baseline as well as at visit 2 (one week post-baseline). Consequently, person-years included in this table do not hold for the sensitivity analyses.